1-(2-Aminopyridin-3-yl)-2,2,2-trifluoroethan-1-one, 98%, 1g

(2R,3S,5R)-5-Chloro-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate, 95%, 100g

Methyl 4-hydroxy-3-(trifluoromethyl)benzoate, 95.0%, 25g

4,5-Dioxo-4,5-dihydro-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid, 97.0%, 50mg

GC-Kapillarsäule ROTI®Cap-1 MS, unpolar, L 25 m, Ø-Innen 0,20 mm, Filmd. 0,20 µm, 1 Stück

(4R)-1-Boc-4-Fluoro-L-proline methyl ester, 97.0%, 1g

Ethyl 3-Methylpyrazole-5-carboxylate>98.0%(GC)1g

Magnetrührstäbe ROTILABO® mit Mittelring, , 8 mm, 40 mm, 1 Stück

4,7-Dichloro-1,10-phenanthroline, 95.0%, 250mg

(2E)-3-Phenyl-1-(pyridin-2-yl)prop-2-en-1-one, 95.0%, 1g

2-Methoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 250mg

HPLC-Vorsäulen NUCLEODUR®, C8 Gravity, 3 µm, 4x3 mm, 3 Stück

5-Chloro-6-methylnicotinic acid, 95%, 1g